1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Concord Drugs
Concord Drugs Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Concord Drugs Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
33.76% Fall from 52W High
-6.7
Dividend yield 1yr %
0
Concord Drugs Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Concord Drugs Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
10.8 Cr | 12.36 Cr | 11.69 Cr | 15.64 Cr | 12.78 Cr |
Concord Drugs Yearly Revenue
| Mar 2024 | Mar 2023 |
|---|---|
44.93 Cr | 52.09 Cr |
Concord Drugs Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
0.23 Cr | 0.04 Cr | 0.03 Cr | -0.34 Cr | -0.24 Cr |
Concord Drugs Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 |
|---|---|
0.47 Cr | 0.99 Cr |
Concord Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
30.50
10Day EMA
30.80
12Day EMA
30.90
20Day EMA
31.30
26Day EMA
31.50
50Day EMA
32.40
100Day EMA
33.70
200Day EMA
35.00
5Day SMA
30.80
10Day SMA
30.90
20Day SMA
31.10
30Day SMA
31.80
50Day SMA
32.30
100Day SMA
34.50
150Day SMA
35.20
200Day SMA
35.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 4372 Rs | 6104 Rs |
Week Rs | 3952 Rs | 5263 Rs |
Month Rs | 5256 Rs | 6896 Rs |
Resistance & Support
30.08
Pivot
Resistance
First Resistance
30.59
Second Resistance
31.40
Third Resistance
31.91
Support
First Support
29.27
Second support
28.76
Third Support
27.95
Relative Strength Index
41.05
Money Flow Index
35.56
MACD
-0.57
MACD Signal
-0.55
Average True Range
1.93
Average Directional Index
14.99
Rate of Change (21)
-8.37
Rate of Change (125)
-17.28
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
29.78 | 26.1 | 44.96 | 30.79 | -3.94% | -4.18% | -17.76% | -20.78% | 3.22% | 0.00% | 0.00 | 41.08 | 0.88 | ||
Veerhealth Care Ltd. | 13.85 | - | - | - | - | - | - | - | - | - | - | - | - | |
Kabra Drugs Ltd. | 11.08 | - | - | - | - | - | - | - | - | - | - | - | - | |
Zenith Healthcare Ltd. | 4.67 | - | - | - | - | - | - | - | - | - | - | - | - | |
Gujarat Inject (Kerala) Ltd. | 21.75 | - | - | - | - | - | - | - | - | - | - | - | - | |
30.26 | 30 | 78.48 | 34.03 | -2.76% | 7.82% | -39.52% | -42.31% | -46.15% | 0.00% | 0.00 | 41.08 | 1.21 | ||
Medicamen Organics Ltd. | 28.90 | - | - | - | - | - | - | - | - | - | - | - | - |
Concord Drugs Latest News
Concord Drugs Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs FAQs
How to buy Concord Drugs shares?
You can easily buy Concord Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Concord Drugs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
